Can Fite Biopharma Ltd (CANF)

$3.81

-0.69

(-15.33%)

Market is closed - opens 7 PM, 23 Jul 2024

Performance

  • $3.75
    $4.69
    $3.81
    downward going graph

    1.57%

    Downside

    Day's Volatility :20.04%

    Upside

    18.76%

    downward going graph
  • $1.81
    $4.69
    $3.81
    downward going graph

    52.49%

    Downside

    52 Weeks Volatility :61.41%

    Upside

    18.76%

    downward going graph

Returns

PeriodCan Fite Biopharma LtdIndex (Russel 2000)
3 Months
93.4%
0.0%
6 Months
90.5%
0.0%
1 Year
25.74%
0.0%
3 Years
-82.32%
-19.9%

Highlights

Market Capitalization
22.2M
Book Value
$0.01
Earnings Per Share (EPS)
-3.0
PEG Ratio
0.0
Wall Street Target Price
13.33
Profit Margin
0.0%
Operating Margin TTM
-1183.23%
Return On Assets TTM
-53.15%
Return On Equity TTM
-142.49%
Revenue TTM
743.0K
Revenue Per Share TTM
0.3
Quarterly Revenue Growth YOY
-21.3%
Gross Profit TTM
810.0K
EBITDA
-8.2M
Diluted Eps TTM
-3.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.39
EPS Estimate Next Year
-0.73
EPS Estimate Current Quarter
-0.26
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 249.87%

Current $3.81
Target $13.33

Technicals Summary

Sell

Neutral

Buy

Can Fite Biopharma Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Can Fite Biopharma Ltd
Can Fite Biopharma Ltd
32.75%
90.5%
25.74%
-82.32%
-86.82%
Moderna, Inc.
Moderna, Inc.
-10.58%
20.19%
-0.41%
-64.88%
800.74%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.55%
12.06%
47.12%
82.44%
245.9%
Novo Nordisk A/s
Novo Nordisk A/s
-6.4%
26.39%
64.35%
193.51%
440.83%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.41%
12.78%
38.89%
147.34%
182.99%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Can Fite Biopharma Ltd
Can Fite Biopharma Ltd
NA
NA
0.0
-1.39
-1.42
-0.53
NA
0.01
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.45
31.45
1.46
44.4
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.05
45.05
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.94
31.94
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Can Fite Biopharma Ltd
Can Fite Biopharma Ltd
NA
$22.2M
-86.82%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.4B
800.74%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.2B
245.9%
31.45
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$591.7B
440.83%
45.05
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.9B
182.99%
31.94
39.46%

Insights on Can Fite Biopharma Ltd

  • Decreasing Revenue

    Revenue is down for the last 8 quarters, 205.0K → 155.0K (in $), with an average decrease of 3.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -1.76M → -1.65M (in $), with an average increase of 6.7% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 60.8% return, outperforming this stock by 33.8%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 193.5% return, outperforming this stock by 275.8%

Company Information

can fite biopharma (canfy) is a biotechnology company based out of 10 bareket street, פ"ת, israel.

Organization
Can Fite Biopharma Ltd
Employees
8
CEO
Dr. Pnina Fishman Ph.D.
Industry
Health Technology

FAQs